<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Designing a Prospective COVID-19 Therapeutic with Reinforcement Learning · HackerPapers discussions</title><link>https://hackerpaper.kaipfister.de/p/2012.01736/</link><description>Collected HN comments and submissions linking this paper.</description><language>en</language><lastBuildDate>Mon, 02 Nov 2026 11:16:22 GMT</lastBuildDate><atom:link href="https://hackerpaper.kaipfister.de/p/2012.01736/feed.xml" rel="self" type="application/rss+xml" /><item><title>Designing a Prospective COVID-19 Therapeutic with Reinforcement Learning — mentioned by nonplussedUltra</title><link>https://news.ycombinator.com/item?id=25342631</link><guid isPermaLink="false">urn:hackerpapers:mention:2012.01736:25342631</guid><pubDate>Tue, 08 Dec 2020 06:53:04 GMT</pubDate><description>&lt;p&gt;Marcin at InstaDeep here, I am one of the people behind DeepChain, and very eager to answer all questions. I am glad to see you noticed our work on protein design for Covid (https://arxiv.org/abs/2012.01736), that is currently presented at NeurIPS. It has been a lot of hard work, but we think it turned out well. You are partially right - the coronavirus work we did earlier this year to a large extent influenced DeepChain development, but - despite overlapping quite a bit - both have slightly different focus. The work you refer to was very result driven, aiming at providing the best result…&lt;/p&gt;&lt;p&gt;&lt;a href="https://hackerpaper.kaipfister.de/p/2012.01736/"&gt;Paper and discussion history&lt;/a&gt;. A mention is not an endorsement.&lt;/p&gt;</description><category>q-bio.BM</category></item></channel></rss>
